GF Fermentech
Innovative biotech company with distinct core technology based on fermentation, biotransformation, purification
Sejong, South Korea · Founded 2000 · $5.9M raised
- Headquarters
- Sejong
- Employees
- 51–200
- Founded
- 2000
- Business Model
- B2B
- Website
- gffermentech.com
- Total Funding
- $5.9M
- Last Round
- $5.9M Corporate RoundMay 2025
- Rounds
- 1
About
GF Fermentech, a subsidiary of HLB Genex, produces bioactive materials with core technologies based on strain development, fermentation, biotransformation, purification, and formulation. Over the past 20 years, the company has developed best-performing microbial strains and highly specialized extraction, purification, and formulation technologies to supply best-in-class bioactive ingredients including Vitamin K2 MK7, Nattokinase, Lactobionic acid, and Phytosphingosine for the nutraceutical and cosmeceutical markets. GF Fermentech also operates as a CDMO, offering contract manufacturing and scale-up from lab to commercial scale (up to 160KL fermentation capacity), and is expanding into synthetic biology for renewable and sustainable bio-products. The company holds GMP and LMO certifications and has been selected for South Korea's Ministry of SMEs and Startups Jump-Up Program.
Summary
GF Fermentech is a Biotech company based in Sejong, South Korea, founded in 2000. It has raised $5.9M in total across 1 round, most recently a $5.9M Corporate Round round in May 2025. Investors include Premier Inc. and Innopolis Partners.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2025
Investors
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
